Market Place
Sourcing Support
Ami Lifesciences Submits US DMF for Tegoprazan
08 Oct 2024 //
PRESS RELEASE
Oxcarbazepine Receives CEP Approval from EDQM
02 Aug 2024 //
PRESS RELEASE
Ami Lifesciences Gets CADIFA Approval for Vonoprazan
02 Aug 2024 //
PRESS RELEASE
Ami Have Received Cep Approval For Rivaroxaban,Used An Anti-Coagulating Agent
08 Apr 2024 //
PRESS RELEASE
Ami received CEP approval Gliclazide. With this approval, we`re one step closer
01 Mar 2024 //
PRESS RELEASE
Ami successful filing of the USDMF for Sitagliptin Phosphate Monohydrate
23 Jan 2024 //
PRESS RELEASE
Ami Lifesciences the USDMF submission of Mirogablin Besylate to the US FDA
01 Jan 2024 //
PRESS RELEASE
USDMF for Finerenone API has been submitted to the USFDA
29 Sep 2023 //
PRESS RELEASE
Ami for being shortlisted as a finalist for the Reg.Achievement of theYear award
28 Sep 2023 //
PRESS RELEASE
CADIFA submission of API Bempedoic Acid to ANVISA, Brazil
01 Sep 2023 //
PRESS RELEASE
Ami Lifesciences being the Highest USDMF filer (#14) in H-1 2023 timeframe Glob
21 Aug 2023 //
PRESS RELEASE
Ami Lifescices announce that USDMF for Daprodustat API has been filed US FDA.
30 Jun 2023 //
PRESS RELEASE
Ami Lifescices inform now EcoVadis Certified, widely recognized international
20 Apr 2023 //
PRESS RELEASE
The USDMF For Empagliflozin API Submitted -Scaled Up A Lean Process created
27 Mar 2023 //
PRESS RELEASE
USDMF for Edoxaban API has been submitted Based On Our Process Expertise
27 Mar 2023 //
PRESS RELEASE
USDMF for Sacubitril Sodium has been submitted With An Innovative Devp Strategy
20 Mar 2023 //
PRESS RELEASE
Sacubitril Valsartan`s USDMF has been submitted to USDMF
09 Mar 2023 //
PRESS RELEASE
We are pleased to announce that the USDMF for Desvenlafaxine Succinate has been submitted to the USFDA.
08 Mar 2023 //
PRESS RELEASE
We are happy to announce our USDMF filing of Dapagliflozin Amorphous to the USFDA.
02 Mar 2023 //
PRESS RELEASE
We are extremely happy to share the successful filling of Febuxostat USDMF with the USFDA
18 Feb 2023 //
PRESS RELEASE
We are delighted to announce that the USDMF for Tadalafil was successfully submitted to the USFDA
17 Feb 2023 //
PRESS RELEASE
We are happy to share that the US DMF for Sevelamer Carbonate was successfully submitted to the USFDA
17 Feb 2023 //
PRESS RELEASE
Ami Lifesciences appoints Amit Kaptain as CEO
16 Sep 2022 //
HEALTH ECONOMIC TIMES
Inaugurated new kilo plant which caters to high value low volume APIs
18 Aug 2021 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.